# Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial

> **NCT04294069** · PHASE4 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 6 (actual)

## Conditions studied

- Preterm Premature Rupture of Membrane

## Interventions

- **DRUG:** Azithromycin 500 mg
- **DRUG:** Azithromycin Oral Product

## Key facts

- **NCT ID:** NCT04294069
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-14
- **Primary completion:** 2020-12-27
- **Final completion:** 2021-04-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294069, "Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04294069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*